Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$1.01	$1.34	$0.96 ▼ $21.49	$5.20M	-2.96	624,358 shs	151,207 shs
NAOV Nanovibronix	$5.39 +7.2%	$8.63	$5.00 ▼ $162.50	$1.39M	1.83	299,379 shs	38,441 shs
QNRX Quoin Pharmaceuticals	$7.28 -0.1%	$8.22	$5.01 ▼ $54.95	$4.29M	1.44	172,283 shs	2,465 shs
STSS Sharps Technology	$7.36 +16.5%	$5.53	$3.36 ▼ $2,145.00	$7.51M	2.15	635,375 shs	204,732 shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	-3.81%	-10.62%	-27.34%	-42.61%	-91.85%
NAOV Nanovibronix	-6.68%	-25.15%	-45.62%	-55.09%	-92.69%
QNRX Quoin Pharmaceuticals	+0.15%	-1.62%	-13.22%	-18.58%	-64.43%
STSS Sharps Technology	+30.58%	+23.44%	+3.78%	+56.05%	+631,999,900.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMIX Autonomix Medical	2.8171 of 5 stars	3.5	2.0	2.4	1.7	1.3
NAOV Nanovibronix	0.2643 of 5 stars	0.0	3.0	0.9	0.0	0.6
QNRX Quoin Pharmaceuticals	0.8533 of 5 stars	0.0	4.0	1.8	0.8	0.6
STSS Sharps Technology	1.7519 of 5 stars	0.0	5.0	2.8	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMIX Autonomix Medical	3.00	Buy	$16.50	1,533.66% Upside
NAOV Nanovibronix	0.00	N/A	N/A	N/A
QNRX Quoin Pharmaceuticals	0.00	N/A	N/A	N/A
STSS Sharps Technology	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	$1.37 per share	N/A
NAOV Nanovibronix	$2.66M	0.52	N/A	N/A	$156.59 per share	0.03
QNRX Quoin Pharmaceuticals	N/A	N/A	N/A	N/A	$4.34 per share	N/A
STSS Sharps Technology	N/A	N/A	N/A	N/A	$14.21 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMIX Autonomix Medical	-$11.41M	-$5.74	N/A	N/A	N/A	N/A	-172.93%	-133.39%	N/A
NAOV Nanovibronix	-$3.70M	-$13.53	N/A	∞	N/A	-380.29%	-45.24%	-34.24%	N/A
QNRX Quoin Pharmaceuticals	-$8.96M	-$41.45	N/A	N/A	N/A	N/A	-210.50%	-99.41%	11/6/2025 (Estimated)
STSS Sharps Technology	-$9.30M	-$1,212.34	N/A	∞	N/A	N/A	-8.72%	-5.30%	N/A

Latest NAOV, AMIX, STSS, and QNRX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2025	Q2 2025	NAOV Nanovibronix	N/A	-$1.03	N/A	-$1.03	N/A	$0.49 million
8/13/2025	Q1 2026	AMIX Autonomix Medical	-$0.98	-$1.07	-$0.09	-$1.07	N/A	N/A
8/13/2025	Q2 2025	STSS Sharps Technology	-$0.94	$3.58	+$4.52	$3.58	$0.25 million	$0.22 million
8/7/2025	Q2 2025	QNRX Quoin Pharmaceuticals	-$6.83	-$6.28	+$0.55	-$6.28	N/A	N/A
5/29/2025	Q4 2025	AMIX Autonomix Medical	N/A	-$0.74	N/A	-$0.74	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	N/A
NAOV Nanovibronix	N/A	N/A	N/A	N/A	N/A
QNRX Quoin Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
STSS Sharps Technology	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMIX Autonomix Medical	N/A	4.57	4.57
NAOV Nanovibronix	N/A	1.05	0.22
QNRX Quoin Pharmaceuticals	N/A	1.96	1.96
STSS Sharps Technology	N/A	4.35	3.67

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMIX Autonomix Medical	10.78%
NAOV Nanovibronix	16.39%
QNRX Quoin Pharmaceuticals	8.63%
STSS Sharps Technology	17.17%

Insider Ownership

Company	Insider Ownership
AMIX Autonomix Medical	32.40%
NAOV Nanovibronix	6.30%
QNRX Quoin Pharmaceuticals	13.46%
STSS Sharps Technology	0.15%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMIX Autonomix Medical	1	5.15 million	3.48 million	N/A
NAOV Nanovibronix	20	258,000	242,000	Not Optionable
QNRX Quoin Pharmaceuticals	4	590,000	509,000	Not Optionable
STSS Sharps Technology	3	1.02 million	1.02 million	Not Optionable

NAOV, AMIX, STSS, and QNRX Headlines

Recent News About These Companies

Sharps Technology, Inc. (NASDAQ:STSS) Short Interest Down 70.5% in July

August 18, 2025 | americanbankingnews.com

Sharps Technology Inc. Stock Grades | STSS | Barron's

July 17, 2025 | barrons.com

Sharps Technology Appoints Paul Danner as Executive Chairman

July 9, 2025 | theglobeandmail.com

Sharps Technology Inc. Company & People | STSS | Barron's

June 29, 2025 | barrons.com

Sharps Technology Inc News (STSS) - Investing.com

June 26, 2025 | investing.com

Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufacturing Facility Upgrades

June 18, 2025 | globenewswire.com

Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET

June 11, 2025 | markets.businessinsider.com

Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET

June 11, 2025 | financialpost.comF

Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET

June 11, 2025 | globenewswire.com

Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET

June 10, 2025 | financialpost.comF

Sharps Technology CEO, Robert Hayes, to Present at the Life Sciences Virtual Investor Forum on June 12 at 9:30AM ET

June 10, 2025 | globenewswire.com

Sharps Technology, Inc. CEO Robert Hayes to Present at Virtual Investor Summit on June 10, 2025

June 9, 2025 | quiverquant.comQ

Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025

June 9, 2025 | globenewswire.com

Sharps Technology stock soars on first commercial shipments

June 4, 2025 | investing.com

Sharps Technology Shares Rise After New Shipments Begin

June 4, 2025 | marketwatch.com

Sharps Technology Begins Shipping Smart Safety Syringes

June 4, 2025 | tipranks.com

Sharps Technology, Inc. Begins Commercial Shipments of Smart Safety Syringes, Marking Revenue Generation Milestone

June 4, 2025 | quiverquant.comQ

Sharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase Agreements

June 4, 2025 | globenewswire.com

Sharps Technology Regains Nasdaq Compliance

May 22, 2025 | tipranks.com

Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule

May 22, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NAOV, AMIX, STSS, and QNRX Company Descriptions

Autonomix Medical NASDAQ:AMIX

$1.01 0.00 (0.00%)

Closing price 04:00 PM Eastern

Extended Trading

$1.01 0.00 (-0.20%)

As of 06:46 PM Eastern

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Nanovibronix NASDAQ:NAOV

$5.39 +0.36 (+7.16%)

Closing price 04:00 PM Eastern

Extended Trading

$5.40 +0.00 (+0.09%)

As of 06:46 PM Eastern

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

Quoin Pharmaceuticals NASDAQ:QNRX

$7.28 -0.01 (-0.07%)

Closing price 03:57 PM Eastern

Extended Trading

$7.15 -0.12 (-1.70%)

As of 05:58 PM Eastern

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.

Sharps Technology NASDAQ:STSS

$7.36 +1.04 (+16.46%)

Closing price 04:00 PM Eastern

Extended Trading

$7.41 +0.05 (+0.68%)

As of 07:19 PM Eastern

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time